Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kastelein

Showing results (51-60 of 184) with videos related to

Pageof 19
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 1999
Activation of the contact system of coagulation does not contribute to the hemostatic imbalance in hypertriglyceridemiaM C Minnema, M E Wittekoek, N Schoonenboom, et al.
Lancet (London, England)|September 18, 2001
Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trialT J Smilde, S van Wissen, H Wollersheim, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1991
A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activityH Funke, A von Eckardstein, P H Pritchard, et al.
Atherosclerosis|October 26, 1999
Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular diseaseM E Wittekoek, E de Groot, M H Prins, et al.
The Journal of Clinical Investigation|May 1, 1997
Sib-pair analysis detects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familial defective ApoBY Y van der Hoek, A Lingenhel, H G Kraft, et al.
Rheumatology (Oxford, England)|August 19, 2007
Systemic inflammation as a risk factor for atherothrombosisS I van Leuven, R Franssen, J J Kastelein, et al.
Clinical and Experimental Rheumatology|August 29, 2003
The outcome of angiography in patients with Raynaud's phenomenon: an unexpected role for atherosclerosis and hypercholesterolemiaR M van Vugt, L Kater, P F Dijkstra, et al.
Journal of Internal Medicine|April 1, 1992
Familial high-density-lipoprotein deficiency causing corneal opacities (fish eye disease) in a family of Dutch descentJ J Kastelein, P H Pritchard, D W Erkelens, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1997
Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemiaS N Pimstone, J C Defesche, S M Clee, et al.
Atherosclerosis|July 1, 1996
Ciprofibrate versus gemfibrozil in the treatment of primary hyperlipidaemiaH C Knipscheer, J C de Valois, B van den Ende, et al.
Pageof 19

Showing results (51-60 of 184) with videos related to

Sort By:
Pageof 19
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 1999
Activation of the contact system of coagulation does not contribute to the hemostatic imbalance in hypertriglyceridemiaM C Minnema, M E Wittekoek, N Schoonenboom, et al.
Lancet (London, England)|September 18, 2001
Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trialT J Smilde, S van Wissen, H Wollersheim, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1991
A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activityH Funke, A von Eckardstein, P H Pritchard, et al.
Atherosclerosis|October 26, 1999
Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular diseaseM E Wittekoek, E de Groot, M H Prins, et al.
The Journal of Clinical Investigation|May 1, 1997
Sib-pair analysis detects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familial defective ApoBY Y van der Hoek, A Lingenhel, H G Kraft, et al.
Rheumatology (Oxford, England)|August 19, 2007
Systemic inflammation as a risk factor for atherothrombosisS I van Leuven, R Franssen, J J Kastelein, et al.
Clinical and Experimental Rheumatology|August 29, 2003
The outcome of angiography in patients with Raynaud's phenomenon: an unexpected role for atherosclerosis and hypercholesterolemiaR M van Vugt, L Kater, P F Dijkstra, et al.
Journal of Internal Medicine|April 1, 1992
Familial high-density-lipoprotein deficiency causing corneal opacities (fish eye disease) in a family of Dutch descentJ J Kastelein, P H Pritchard, D W Erkelens, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1997
Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemiaS N Pimstone, J C Defesche, S M Clee, et al.
Atherosclerosis|July 1, 1996
Ciprofibrate versus gemfibrozil in the treatment of primary hyperlipidaemiaH C Knipscheer, J C de Valois, B van den Ende, et al.
Pageof 19